Benzinga | Dec 9, 2021 09:37PM EST

Ovid Therapeutics Receives Notice Of Allowance For U.S. Patent Titled 'USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS'

https://patentcenter.uspto.gov/#!/applications/17066389/ifw/docs